nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Author Index
|
|
|
2009 |
19 |
S2 |
p. S169-S170 2 p. |
artikel |
2 |
Calendar of Meetings of the European College of Neuropsychopharmacology
|
|
|
2009 |
19 |
S2 |
p. iii- 1 p. |
artikel |
3 |
Editorial Board
|
|
|
2009 |
19 |
S2 |
p. i-ii nvt p. |
artikel |
4 |
Keyword Index
|
|
|
2009 |
19 |
S2 |
p. S171- 1 p. |
artikel |
5 |
KL.01 Bipolar disorders
|
Goodwin, G.M. |
|
2009 |
19 |
S2 |
p. S103- 1 p. |
artikel |
6 |
KL.02 The European First Episode Schizophrenia Trial: are all antipsychotics created equal?
|
Kahn, R. |
|
2009 |
19 |
S2 |
p. S103-S104 2 p. |
artikel |
7 |
ME1 Treatment of schizophrenia
|
Arango, C. |
|
2009 |
19 |
S2 |
p. S105- 1 p. |
artikel |
8 |
ME2 Use of dual action antidepressants
|
Kasper, S. |
|
2009 |
19 |
S2 |
p. S105-S106 2 p. |
artikel |
9 |
P.1.10 Acute hypoxia of early organogenesis: influence on stress-realising system of descendants
|
Graf, A. |
|
2009 |
19 |
S2 |
p. S138- 1 p. |
artikel |
10 |
P.1.14 Antiaggressive and sedative effect of alpha2-adrenoceptor agonist naphthylmedetomidine in rabbits and monkeys
|
Votava, M. |
|
2009 |
19 |
S2 |
p. S141-S142 2 p. |
artikel |
11 |
P.3.01 Aripiprazole reduces risperidone-induced hyperprolactinemia: two case reports
|
Capasso, A. |
|
2009 |
19 |
S2 |
p. S151- 1 p. |
artikel |
12 |
P.7.03 Brain-derived neurotrophic factor gene val66met polymorphism, smoking and suicide-related thoughts in adolescents
|
Hiio, K. |
|
2009 |
19 |
S2 |
p. S165- 1 p. |
artikel |
13 |
P.1.16 Characterisation of ligand binding to melanocortin 4 receptors by fluorescence polarisation
|
Veiksina, S. |
|
2009 |
19 |
S2 |
p. S142-S143 2 p. |
artikel |
14 |
P.1.15 Chronic citalopram treatment counteracts kainic acid induced aberrations in adult mouse hippocampus
|
Helmdorf, M. |
|
2009 |
19 |
S2 |
p. S142- 1 p. |
artikel |
15 |
P.2.02 Citalopram and venlafaxine in the treatment of depressive disorder in elderly patients
|
Galecki, P. |
|
2009 |
19 |
S2 |
p. S144-S145 2 p. |
artikel |
16 |
P.8.03 Cognitive dysfunctions in a group of patients with fibromyalgia and its consequences for treatment
|
Samborski, W. |
|
2009 |
19 |
S2 |
p. S167-S168 2 p. |
artikel |
17 |
P.3.04 Cognitive functions and level of stress in schizophrenia-like psychoses before treatment and during quetiapine therapy
|
Wysokinski, A. |
|
2009 |
19 |
S2 |
p. S153-S154 2 p. |
artikel |
18 |
P.2.07 Comparison of the effectiveness of trazodone and venlafaxine therapy in patients with diagnosed depressive disorders
|
Zboralski, K. |
|
2009 |
19 |
S2 |
p. S147-S148 2 p. |
artikel |
19 |
P.3.06 Composite tardive dystonia associated with antipsychotic drugs for treatment of bipolar affective disorder: a case study
|
Adomaitiene, V. |
|
2009 |
19 |
S2 |
p. S154-S155 2 p. |
artikel |
20 |
P.2.10 Cost-effectiveness in the pharmacoeconomics of depression treatment
|
Kavaliauskiene, L. |
|
2009 |
19 |
S2 |
p. S150- 1 p. |
artikel |
21 |
P.1.04 Depression-like behaviour and reduced levels of the serotonin reuptake transporter in the brain regions of NCAM deficient mice
|
Aonurm-Helm, A. |
|
2009 |
19 |
S2 |
p. S133-S134 2 p. |
artikel |
22 |
P.2.01 Duloxetine in the treatment of bulimia nervosa: a case report
|
Capasso, A. |
|
2009 |
19 |
S2 |
p. S143-S144 2 p. |
artikel |
23 |
P.1.02 Effect of repeated haloperidol administration on maternal behaviour of albino rats
|
Dobryakova, Y.V. |
|
2009 |
19 |
S2 |
p. S132- 1 p. |
artikel |
24 |
P.1.03 Effects of chronic citalopram treatment on the kainic acid induced neurogenesis in adult mouse hippocampus
|
Jaako, K. |
|
2009 |
19 |
S2 |
p. S132-S133 2 p. |
artikel |
25 |
P.4.01 Effects of group II metabotropic glutamate receptor antagonist, MGS0039 in rodent tests of anxiety-like behaviour
|
Stachowicz, K. |
|
2009 |
19 |
S2 |
p. S156-S157 2 p. |
artikel |
26 |
P.2.06 Effects of serotoninergic agents on depressive-like behaviour and anxiety in old thyroidectomized rats
|
Masalova, O. |
|
2009 |
19 |
S2 |
p. S147- 1 p. |
artikel |
27 |
P.2.05 Effects of the NMDA antagonist MK-801 on the behavioural manifestations of antidepressants in rats
|
Pruus, K. |
|
2009 |
19 |
S2 |
p. S146- 1 p. |
artikel |
28 |
P.7.01 Hyperactive and inattentive symptoms, hostile family environment, and ADRA2A C-1291G polymorphism in healthy adolescents
|
Kiive, E. |
|
2009 |
19 |
S2 |
p. S163-S164 2 p. |
artikel |
29 |
P.7.02 Hypoxic impact in the period of early organogenesis disturbs corticosterone levels in the adrenal glands and blood of pregnant rats
|
Dunaeva, T.Y. |
|
2009 |
19 |
S2 |
p. S164- 1 p. |
artikel |
30 |
P.1.13 Identification of clusters of co-regulated genes that may underlie the phenotypes of high and low exploring rats
|
Alttoa, A. |
|
2009 |
19 |
S2 |
p. S140-S141 2 p. |
artikel |
31 |
P.6.01 Incentive role of amygdaloid CRF receptors in the reinforcing effects of psychoactive drugs in rats: a new concept
|
Shabanov, P. |
|
2009 |
19 |
S2 |
p. S161-S162 2 p. |
artikel |
32 |
P.4.03 Influence of antenatal intermittent normobaric hypoxia in the period of early organogenesis on the behaviour of rats
|
Trofimova, L. |
|
2009 |
19 |
S2 |
p. S158-S159 2 p. |
artikel |
33 |
P.4.02 Influence of drugs with anxiolytic properties on serotonergic receptors in the rat brain
|
Kowalczyk, M. |
|
2009 |
19 |
S2 |
p. S157-S158 2 p. |
artikel |
34 |
P.4.04 Interaction between CRF and noradrenergic system in the rat frontal cortex
|
Zieba, B. |
|
2009 |
19 |
S2 |
p. S159-S160 2 p. |
artikel |
35 |
P.1.06 Ketanzerine improves cognitive performance in ovariectomized rats with scopolamine-induced amnesia
|
Fedotova, J. |
|
2009 |
19 |
S2 |
p. S135- 1 p. |
artikel |
36 |
P.2.08 Long term follow up of adolescent depression: history of drug prescriptions
|
Päären, A. |
|
2009 |
19 |
S2 |
p. S148-S149 2 p. |
artikel |
37 |
P.8.01 Mental retardation – psychopathology, diagnosing and treatment – forty years after Webster's theory
|
Bobinska, K. |
|
2009 |
19 |
S2 |
p. S165-S166 2 p. |
artikel |
38 |
P.1.08 Mice deficient in ST8SiaII demonstrate working memory impairment: a core feature of schizophrenia-like phenotype
|
Malinovskaja, K. |
|
2009 |
19 |
S2 |
p. S136-S137 2 p. |
artikel |
39 |
P.3.05 Need-adapted treatment of first episode psychotic patients: 2-year follow-up
|
Küünarpuu, H. |
|
2009 |
19 |
S2 |
p. S154- 1 p. |
artikel |
40 |
P.1.11 Neurochemical effects of prenatal exposure of selective M- and N-cholinoblockers in early ontogeny
|
Bairamov, A.A. |
|
2009 |
19 |
S2 |
p. S138-S139 2 p. |
artikel |
41 |
P.3.02 Osteopenia by risperidone-induced hyperprolactinemia: a case report
|
Capasso, A. |
|
2009 |
19 |
S2 |
p. S151-S152 2 p. |
artikel |
42 |
P.3.03 Population study of remission rate in an outpatient psychiatric service in Moscow
|
Potapov, A. |
|
2009 |
19 |
S2 |
p. S152-S153 2 p. |
artikel |
43 |
P.3.08 Possible neurophysiological endophenotypes of schizophrenia at the different stages of illness progression
|
Lebedeva, I. |
|
2009 |
19 |
S2 |
p. S156- 1 p. |
artikel |
44 |
P.1.07 Prodrugs of 3-hydroxy-7-brom-5-phenyl- 1,4-benzdiazepin-2-on for oral delivery
|
Kravchenko, I. |
|
2009 |
19 |
S2 |
p. S135-S136 2 p. |
artikel |
45 |
P.1.09 Psychoemotional state and cancerous growth metastases: possible roles of vasopressin
|
Popova, N. |
|
2009 |
19 |
S2 |
p. S137- 1 p. |
artikel |
46 |
P.3.07 Quality of life of family members of patients with first episode psychosis and family-centered treatment
|
Reinson, L. |
|
2009 |
19 |
S2 |
p. S155-S156 2 p. |
artikel |
47 |
P.1.12 Response to chronic social stress in the rat depends on persistent differences in sucrose consumption
|
Kanarik, M. |
|
2009 |
19 |
S2 |
p. S139-S140 2 p. |
artikel |
48 |
P.2.09 Serotonin transporter gene promoter polymorphism and family relations: effect on symptoms of depression in adolescents
|
Kurrikoff, T. |
|
2009 |
19 |
S2 |
p. S149-S150 2 p. |
artikel |
49 |
P.6.02 Substance use and serotonin transporter gene L/S polymorphism in children and adolescents
|
Merenäkk, L. |
|
2009 |
19 |
S2 |
p. S162-S163 2 p. |
artikel |
50 |
P.8.02 The hydrolysis of 7-bromo-3-hydroxy-5-phenyl-1,2-dihydro-3H-1,4-benzodiazepine-2-one esters by pig liver microsomes
|
Romanovskaya, I.I. |
|
2009 |
19 |
S2 |
p. S166-S167 2 p. |
artikel |
51 |
P.1.05 The influence of the new analogue of AVP(6–9) – Ac-D-SPRG on the behaviour in white rats
|
Belyakova, A. |
|
2009 |
19 |
S2 |
p. S134- 1 p. |
artikel |
52 |
P.1.01 The kinurenine pathway gene polymorphisms of the tryptophan metabolism do not play a role in Alzheimer's disease
|
Juhasz, A. |
|
2009 |
19 |
S2 |
p. S131- 1 p. |
artikel |
53 |
P.4.06 Trazodone – efficacious way to treat adjustment disorders
|
Galecki, P. |
|
2009 |
19 |
S2 |
p. S160-S161 2 p. |
artikel |
54 |
P.2.04 Trends in treating depression of inpatients with ischaemic heart disease in university hospital
|
Adomaitiene, V. |
|
2009 |
19 |
S2 |
p. S145-S146 2 p. |
artikel |
55 |
P.4.05 Trends in use of diazepam in university hospital
|
Adomaitiene, V. |
|
2009 |
19 |
S2 |
p. S160- 1 p. |
artikel |
56 |
S.1.02 Antidepressant pharmacotherapy – 2009 and beyond
|
Nutt, D. |
|
2009 |
19 |
S2 |
p. S108-S109 2 p. |
artikel |
57 |
S.2.04 Are antidepressants really endowed with anxiolytic properties in relevant animal models?
|
Hamon, M. |
|
2009 |
19 |
S2 |
p. S116-S117 2 p. |
artikel |
58 |
S.2.01 Can PTSD be prevented? Strategic interventions in the ‘golden hours’
|
Zohar, J. |
|
2009 |
19 |
S2 |
p. S111-S113 3 p. |
artikel |
59 |
S.1.05 Depression and general medical condition
|
Bunevicius, R. |
|
2009 |
19 |
S2 |
p. S111- 1 p. |
artikel |
60 |
S.3.05 Developmental programming of anxiety in mice
|
Gross, C. |
|
2009 |
19 |
S2 |
p. S122-S123 2 p. |
artikel |
61 |
S.3.01 Gene–environment interactions in schizophrenia
|
Mors, O. |
|
2009 |
19 |
S2 |
p. S119-S120 2 p. |
artikel |
62 |
S.1.03 Male depression and suicide
|
Rutz, W. |
|
2009 |
19 |
S2 |
p. S109- 1 p. |
artikel |
63 |
S.3.02 Molecular genetics of ADHD
|
Lesch, K.P. |
|
2009 |
19 |
S2 |
p. S120-S121 2 p. |
artikel |
64 |
S.4.03 Neural cell adhesion molecule and depression-like phenotype in mice
|
Zharkovsky, A. |
|
2009 |
19 |
S2 |
p. S126-S127 2 p. |
artikel |
65 |
S.4.01 Neuroplasticity and neuronal cell adhesion molecules
|
Bock, E. |
|
2009 |
19 |
S2 |
p. S123-S125 3 p. |
artikel |
66 |
S.1.01 New molecules for mood disorders; the NewMood EU project
|
Deakin, J.F.W. |
|
2009 |
19 |
S2 |
p. S107-S108 2 p. |
artikel |
67 |
S.4.05 Novel neurotrophic factors for the treatment of neurodegenerative diseases
|
Saarma, M. |
|
2009 |
19 |
S2 |
p. S128-S129 2 p. |
artikel |
68 |
S.3.03 Pharmacogenetic studies in depression
|
Maron, E. |
|
2009 |
19 |
S2 |
p. S121-S122 2 p. |
artikel |
69 |
S.4.04 Pharmacological induction of neuronal plasticity in the visual cortex
|
Castrén, E. |
|
2009 |
19 |
S2 |
p. S127-S128 2 p. |
artikel |
70 |
S.1.04 Prediction of suicide in mood disorders
|
Rihmer, Z. |
|
2009 |
19 |
S2 |
p. S110-S111 2 p. |
artikel |
71 |
S.2.02 The brain prepared to become anxious: predisposing neurobiology in animals and humans
|
Harro, J. |
|
2009 |
19 |
S2 |
p. S113-S115 3 p. |
artikel |
72 |
S.2.03 The role of 5-HT1A receptors in emotional memory: implications for anxiety and depression
|
Ögren, S.O. |
|
2009 |
19 |
S2 |
p. S115-S116 2 p. |
artikel |
73 |
S.4.02 Time course in evolution of brain amyloid and its relation to cognitive impairment in Alzheimer's disease
|
Nordberg, A. |
|
2009 |
19 |
S2 |
p. S125-S126 2 p. |
artikel |
74 |
S.2.05 Wolframin (WFS1) deficient mice display increased anxiety and reduced adaptation in a novel environment
|
Vasar, E. |
|
2009 |
19 |
S2 |
p. S117-S119 3 p. |
artikel |